Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/11/2010EP2099763B1 2-aminoquinolines as 5-ht(5a) receptor antagonists
08/11/2010EP2049529B1 Substituted diazepan orexin receptor antagonists
08/11/2010EP1937688B1 Imidazo benzodiazepine derivatives
08/11/2010EP1881979B1 Novel oxadiazole derivatives and their medical use
08/11/2010EP1809605B1 Quinolines as allosteric enhancers of the gaba-b receptors
08/11/2010EP1797051B1 Benzoxazine and quinoxaline derivatives and uses
08/11/2010EP1499615B1 Thienyl compounds
08/11/2010EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN201542233U Multifunctional shape-protecting health care medical pillow for babies
08/11/2010CN1942179B Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
08/11/2010CN1840162B Compound total extract of compound cape jasmine, ginger and fermented soybean, its preparation and use
08/11/2010CN1833692B False portulaca oleracea extracts, its prepn. and usage
08/11/2010CN1698879B Product having sobering up and liver protecting functions and its preparation method and usage
08/11/2010CN101802197A Single-chain FC (ScFc) regions, binding polypeptides comprising same, and methods related thereto
08/11/2010CN101802174A Cell growth method and pharmaceutical preparation for tissue repair and regeneration
08/11/2010CN101802007A Monoclonal anti-beta amyloid antibody
08/11/2010CN101801980A tricyclic heterocyclic derivatives
08/11/2010CN101801971A Deazapurines useful as inhibitors of janus kinases
08/11/2010CN101801965A Indole compounds as an inhibitor of cellular necrosis
08/11/2010CN101801955A Pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/11/2010CN101801951A 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1, 4'] bipyridinyl-2'-ones
08/11/2010CN101801950A Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
08/11/2010CN101801932A Substituted nicotinamide compounds and the use thereof in pharmaceutical products
08/11/2010CN101801927A Piperidine derivatives as nk3 receptor antagonists
08/11/2010CN101801924A Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto
08/11/2010CN101801918A Monoamide derivatives as orexin receptor antagonists
08/11/2010CN101801907A Compounds isolated from antrodia cinnamomea and use thereof
08/11/2010CN101801461A [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
08/11/2010CN101801415A Sustained delivery formulations of risperidone compounds
08/11/2010CN101801406A Tissue kallikrein for the treatment of diseases associated with amyloid protein
08/11/2010CN101801398A Cognitive disorder-ameliorating agent
08/11/2010CN101801396A methods and compositions for treating neural degeneration
08/11/2010CN101801372A Combinations of SAP depleting agents and anti-SAP antibodies
08/11/2010CN101801368A Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid
08/11/2010CN101798561A Dangshen health-care vinegar and production method thereof
08/11/2010CN101798338A Anti-opioid peptide antagonist peptide and application thereof
08/11/2010CN101798333A Tetraterpene compound and derivatives thereof for treating cancer, inflammation and central nervous system diseases
08/11/2010CN101798317A N-substituted aminothiazole morphinan compound and preparation method and applications thereof
08/11/2010CN101798306A Uncaria alkaloid monomer as well as preparation method and application thereof
08/11/2010CN101798305A Tetrahydronaphthyridine derivates useful as histamine h3 receptor ligands
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101798297A Chemical synthesis method of laetispicine
08/11/2010CN101797372A Fire-friend cold capsule
08/11/2010CN101797351A Traditional Chinese medicine for preventing senile dementia
08/11/2010CN101797336A Granule preparation for treating cold and preparation method thereof
08/11/2010CN101797333A Medicinal composition for treating intracranial tumours
08/11/2010CN101797317A Chinese medicinal composition for relieving mind and calming nerve
08/11/2010CN101797316A Traditional Chinese medicine for treating hyperpyrexia and infantile convulsion and preparation method thereof
08/11/2010CN101797307A Phenethyl alcohol glycoside-containing callicarpa kochiana extractive and preparation method thereof
08/11/2010CN101797292A Chinese medical pillow inner for curing insomnia and preparation method thereof
08/11/2010CN101797282A Novel compound propolis preparation and preparation method thereof
08/11/2010CN101797279A Health care product with dealcoholic function
08/11/2010CN101797273A Method for extracting total flavonoid glycoside from ginkgo leaves
08/11/2010CN101797267A Medical composite for preventing and curing Alzheimer's disease
08/11/2010CN101797261A Method for preparing monostalotetrahexosyl gangliside GM1 compound
08/11/2010CN101797255A Tablet capsule filled with dihydroergocryptine mesylate A tablet and caffeine tablet in capsule
08/11/2010CN101797244A Levodopa/benserazide orally disintegrating tablet
08/11/2010CN101797243A Composition containing levodopa and borneol, and application thereof
08/11/2010CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
08/11/2010CN101797236A Rivastigmine orally disintegration tablet and preparation method thereof
08/11/2010CN101797228A Method for preparing oryzanol microemulsion
08/11/2010CN101797222A Morphine sulfate sustained/controlled-release suppository and preparation method thereof
08/11/2010CN101797221A Oral drug delivery system comprising high viscosity liquid carrier materials
08/11/2010CN101797215A Human body health care shower gel
08/11/2010CN101361984B Use of Dpys 12 gene in preparing medicine for inhibiting or promoting early neurogenesis
08/11/2010CN101317866B Traditional Chinese medicine for treating facial paralysis
08/11/2010CN101199819B Medicament compound for treating Parkinson syndrome
08/11/2010CN101108236B Hemiparalysis restoration pill
08/11/2010CN101069734B Chinese medicine composition for vascular cretinism and preparing method therefor
08/11/2010CN101066267B Solid oral medicine composition containing aripiprazole microcrystal
08/11/2010CN101037436B L-stepholidine (l-SPD) derivatives, preparation method and usage thereof
08/11/2010CN101011409B Collunarium containing vitamin B12
08/11/2010CN101006047B TRPV1 agonists, formulations containing them and uses thereof
08/11/2010CN100999546B Polypeptide compound with aza-containing heterocyclic modification and its application
08/10/2010USRE41489 Method of providing sustained analgesia with buprenorphine
08/10/2010US7772427 Uses for amino acid anticonvulsants
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772240 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
08/10/2010US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches
08/10/2010US7772221 2-ethyl-hexanoic acid ((1S,4R,5S,8S,14R)-5-benzyl-4-hydroxy-18-methoxy-7-oxo-13-oxa-2,6-diaza-tricyclo[12.6.1.015,20]henicosa-10, 15(20),16,18-tetraen-8-yl)-methyl-amide; Alzheimer's Disease, Down's Syndrome; inhibitors of beta-secretase processing of amyloid precursor proteins
08/10/2010US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
08/10/2010US7771927 Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
08/10/2010US7771748 Reducing smoking; side effect reduction
08/10/2010CA2559397C Substituted morpholine and thiomorpholine derivatives
08/10/2010CA2547334C Methods and compositions for deterring abuse of opioid containing dosage forms
08/10/2010CA2535646C Cyclopropyl derivatives as nk3 receptor antagonists
08/10/2010CA2527315C Imidazole derivatives as glutamate receptor antagonists
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2471147C Nitric oxide donors for treatment of disease and injury
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/10/2010CA2462694C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
08/10/2010CA2444506C Orodispersible effervescent tablets
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents